[LXRX] YoY Annual Result on 31-Dec-2012 [#FY]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
11-Mar-2013
Financial Year
2012
Quarter
31-Dec-2012 [#FY]
Profit Trend
YoY- 5.17%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Annual Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 130,014 22,854 2,222 1,089 1,849 4,908 10,700 51.59%
PBT -4,682 -100,364 -104,126 -110,211 -116,215 -101,801 -93,419 -39.26%
Tax 5,995 -70 -833 -1,971 -2,359 -26 -102 -
NP -4,682 -100,294 -104,126 -110,211 -116,215 -101,775 -82,780 -38.03%
Tax Rate - - - - - - - -
Total Cost 134,696 123,148 106,348 111,300 118,064 106,683 93,480 6.27%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin -3.60 -438.85 -4,686.14 -10,120.39 -6,285.29 -2,073.66 -773.64 -59.12%
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
EPS -0.05 -1.31 -1.42 -1.58 -2.39 -2.35 -3.98 -51.76%
EPS Diluted -0.05 -1.31 -1.42 -1.58 -2.39 -2.35 -3.98 -51.76%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.